Consensus ABIONYX Pharma

Equities

ABNX

FR0012616852

Market Closed - Euronext Paris Other stock markets 09:56:32 2024-04-24 am EDT			5-day change	1st Jan Change
1.04 ^EUR	-1.52%		-4.94%	-19.25%

Mar. 14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
Mar. 11	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

a07d7c4996776befacc5259628e34eed.374-2RYrFzwt5u-WaKk4_HLaA0Xz1PjowLXFRybtPqg.nPph6Xd8ZVZEnLXVENB6lCawZDKdgaqHsvyhdUqXWfzsznqIRVh5VR-piA~5b71551c4dcd1f294c50da641ca01971

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.056 EUR

Average target price

10.5 EUR

Spread / Average Target

+894.32%

High Price Target

10.5 EUR

Spread / Highest target

+894.32%

Low Price Target

10.5 EUR

Spread / Lowest Target

+894.32%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar